» Articles » PMID: 20522872

An Evaluation of Neurophysiological Criteria Used in the Diagnosis of Motor Neuron Disease

Overview
Date 2010 Jun 5
PMID 20522872
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: New criteria for the neurophysiological diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) were recently proposed at an international symposium in Awaji-shima, Japan. They differ from the accepted revised El-Escorial criteria by considering fasciculation potentials to be evidence of acute denervation. In addition, when assessing diagnostic certainty, the Awaji-shima criteria equate electrodiagnostic evidence of lower motor neuron dysfunction with clinical examination findings.

Methods: A retrospective review of 205 consecutive sets of notes was performed, from patients who underwent neurophysiological assessment for suspected MND. The clinical signs and neurophysiological findings were combined according to the two sets of criteria (revised El-Escorial and Awaji-shima), and the diagnoses reached were compared with the interval diagnosis, to establish the sensitivities and specificities of each protocol.

Results: An interval diagnosis of MND was recorded in 107 patients. The sensitivity of the Awaji-shima criteria in reaching a diagnosis of MND was 60.7% and the revised El-Escorial 28%, with a specificity of 95.9% for both criteria. The Awaji-shima criteria increased the sensitivity of diagnosis without affecting the specificity.

Conclusion: Accepting EMG evidence of fasciculations as evidence of acute denervation increases the diagnostic certainty of MND, and the new criteria allow earlier diagnosis of MND without increasing the false-positive rate.

Citing Articles

Gold Coast Criteria in ALS Diagnosis: A Real-World Experience.

Ferullo L, Risi B, Caria F, Olivieri E, Poli L, Gazzina S Brain Sci. 2024; 14(11).

PMID: 39595818 PMC: 11592046. DOI: 10.3390/brainsci14111055.


Understanding Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis, and Therapeutic Advances.

Rizea R, Corlatescu A, Costin H, Dumitru A, Ciurea A Int J Mol Sci. 2024; 25(18).

PMID: 39337454 PMC: 11432652. DOI: 10.3390/ijms25189966.


Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study.

Issa N, Aydin S, Polley E, Carberry N, Garret M, Smith S PLoS One. 2024; 19(5):e0303053.

PMID: 38776297 PMC: 11111088. DOI: 10.1371/journal.pone.0303053.


Electrodiagnostic profile of conduction slowing in amyotrophic lateral sclerosis.

Souayah N, Pahwa A, Jaffry M, Patel T, Nasar A, Chong Z Heliyon. 2023; 9(8):e18400.

PMID: 37520962 PMC: 10382630. DOI: 10.1016/j.heliyon.2023.e18400.


Modulation of spontaneous motor unit potentials by a new motor cortical magnetic stimulation method in amyotrophic lateral sclerosis.

Helekar S, Thonhoff J, John B, Nguyen L, Rosenfield D, Appel S J Neurol. 2022; 269(10):5487-5496.

PMID: 35704101 DOI: 10.1007/s00415-022-11214-8.